Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Provencher

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Gastrointestinal Endoscopy|July 1, 1997
Does an open access system properly utilize endoscopic resources?G Zuccaro, K Provencher
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Gastrointestinal Endoscopy|July 1, 1997
Does an open access system properly utilize endoscopic resources?G Zuccaro, K Provencher
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Pageof 1